Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 26 (RPL31P26)

Target
RPL31P26
Molecular classification
Other (Pseudogene)
01

Overview

RPL31P26 refers to “ribosomal protein L31 pseudogene 26,” a *pseudogene* corresponding to the functional gene *RPL31*, which encodes a ribosomal protein that is part of the large 60S ribosomal subunit. Pseudogenes like RPL31P26 are non-functional genomic DNA sequences similar to normal genes but typically do not encode a functional protein due to mutations, truncations, or regulatory sequence loss. There is no evidence that RPL31P26 is transcribed or translated, nor are there known biological functions, disease associations, or drug interactions specific to this pseudogene[2][4][5][11][12][7][8]. Essential context: - The *parent gene* RPL31 is involved in basic cellular protein synthesis, and multiple pseudogenes have arisen from it throughout the genome[1][3][6]. - *Pseudogenes* are not therapeutically relevant targets as they generally lack transcription and translation, and they do not encode receptors, enzymes, transporters, or other druggable proteins[7][8]. - No molecular functions, disease roles, or drug associations are attributed to RPL31P26 specifically; any such information applies to the functional RPL31 gene, not to its pseudogenes. Summary: RPL31P26 is a *processed pseudogene* of the ribosomal protein L31 gene and is not a protein-coding or therapeutic target; it has no roles in disease, no associated drugs, and no established biological functions[2][4][5][12].

Other names
RPL31_7_527RPL31P26

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 26 (RPL31P26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 26 (RPL31P26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call